Nazartinib in EGFR Thr790Met-mutant non-small-cell lung cancer

Lancet Respir Med. 2020 Jun;8(6):528-529. doi: 10.1016/S2213-2600(19)30361-3. Epub 2020 Jan 15.

Authors

Jacek Jassem¹, Rafał Dziadziuszko²

Affiliations

¹ Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk 80-211, Poland. Electronic address: jjassem@gumed.edu.pl.
² Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk 80-211, Poland.

PMID: 31954623
DOI: 10.1016/S2213-2600(19)30361-3

No abstract available

Publication types

Comment

MeSH terms

Adult
Benzimidazoles
Carcinoma, Non-Small-Cell Lung*
ErbB Receptors
Humans
Lung Neoplasms*
Nicotine / analogs & derivatives

Substances

Benzimidazoles
Nicotine
EGFR protein, human
ErbB Receptors
nazartinib